enzyme kinetic module of sigmaplot program (SYSTAT)
SYSTAT is a verified supplier 
90
Structured Review
SYSTAT
enzyme kinetic module of sigmaplot program
Enzyme Kinetic Module Of Sigmaplot Program, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzyme+kinetic+module+of+sigmaplot+program/enzyme+kinetics+module+of+sigmaplot+12+5/pm18930704-132-32-34
Average 90 stars, based on 1 article reviews
Enzyme Kinetic Module Of Sigmaplot Program, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzyme+kinetic+module+of+sigmaplot+program/enzyme+kinetics+module+of+sigmaplot+12+5/pm18930704-132-32-34
Average 90 stars, based on 1 article reviews
enzyme kinetic module of sigmaplot program - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Inhibition:Article Title: Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions. Article Snippet: Vicagrel, an antiplatelet drug candidate targeting platelet P2Y12 receptor and has finished its phase II clinical trial.. The inhibition of six major cytochrome P450 enzymes (P450) (CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4) and six UDP-glucuronosyltransferases (UGT) (UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9, and UGT2B7) by vicagrel was evaluated using pooled human liver microsomes and specific probe substrates.. Physiology-based pharmacokinetic (PBPK) simulation was further applied to predict the in vivo drugdrug interaction (DDI) potential between vicagrel and bupropion as well as S-mephenytoin. Article Title: Metabolite phenotyping of kobusin and identification of glutathione conjugates with kobusin catechol metabolite. Article Snippet: .. The plots were fitted to the Michaelis-Menten equation [v = Vmax⋅S/(Km + S)], the Hill equation model [v = Vmax⋅Sn/(Kmn + Sn)], or substrate inhibition model [v = Vmax⋅S/(Km + S + S2/Ki)] using other:Article Title: Importance of Rare DPYD Genetic Polymorphisms for 5-Fluorouracil Therapy in the Japanese Population. Article Snippet: Kinetic data were analyzed using Article Title: Importance of Rare DPYD Genetic Polymorphisms for 5-Fluorouracil Therapy in the Japanese Population Article Snippet: Kinetic data were analyzed using Article Title: Functional Characterization of 12 Dihydropyrimidinase Allelic Variants in Japanese Individuals for the Prediction of 5-Fluorouracil Treatment-Related Toxicity. Article Snippet: The drug 5-fluorouracil (5-FU) is the first-choice chemotherapeutic agent against advanced-stage cancers.. However, 10% to 30% of treated patients experience grade 3 to 4 toxicity.. The deficiency of dihydropyrimidinase (DHPase), which catalyzes the second step of the 5-FU degradation pathway, is correlated with the risk of developing toxicity. Software:Article Title: Metabolite phenotyping of kobusin and identification of glutathione conjugates with kobusin catechol metabolite. Article Snippet: .. The plots were fitted to the Michaelis-Menten equation [v = Vmax⋅S/(Km + S)], the Hill equation model [v = Vmax⋅Sn/(Kmn + Sn)], or substrate inhibition model [v = Vmax⋅S/(Km + S + S2/Ki)] using Concentration Assay:Article Title: Acinetobacter baumannii DacC influences cell shape, biofilm formation and physiological fitness by manifesting DD-carboxypeptidase, and β-lactamase dual-enzyme activities Article Snippet: .. The data was analysed using the |